This webinar examines the growing trend of transparency worldwide and its affect on medical device companies specifically.
The movement towards transparency in interactions between healthcare practitioners ("HCPs") and the life sciences industry began in the United States with the Open Payments program, but has quickly expanded well beyond US borders. Geographically, the global transparency movement extends to the Pacific Rim, as the Japanese and Australian pharmaceutical industry groups have recently modified their individual-level reporting requirements.
Presenter: Brian P. Sharkey, Vice President
Disclaimer: Please keep in mind that laws are constantly changing and the content of materials on this website may not reflect their current status.